Article info

Download PDFPDF
Optimalisation of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A–677C alleles on probability to respond
  1. W M Kooloos, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, PO Box 9600, NL 2300 RC Leiden, The Netherlands; w.m.kooloos{at}lumc.nl
View Full Text

Citation

Kooloos WM, Wessels JAM, van der Kooij SM, et al
Optimalisation of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A–677C alleles on probability to respond

Publication history

  • Accepted October 29, 2008
  • First published July 15, 2009.
Online issue publication 
July 15, 2009

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.